Related Experiment Video
Updated: May 14, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Summary
Oncologists resist health plan efforts to control high biotech cancer drug costs. They argue that current drug pricing models are essential for covering cancer care services.
Area of Science:
- Oncology
- Health Economics
- Managed Care
Background:
- Biotech cancer drugs represent a significant and growing expense within healthcare.
- Managed care organizations aim to control rising healthcare costs, particularly for high-cost medications.
- Physician autonomy in treatment decisions is a key aspect of medical practice.
Purpose of the Study:
- To examine the conflict between health plans' cost containment strategies and oncologists' drug purchasing practices.
- To understand the rationale behind oncologists' defense of their current drug pricing models.
- To explore the perspectives of both health plans and oncologists in the managed care of cancer drugs.
Main Methods:
- Analysis of the managed care landscape concerning oncology drug expenses.
- Review of common practices in drug purchasing and pricing by oncology practices.
- Examination of the arguments presented by health plans and oncologists regarding drug costs and care delivery.
Main Results:
- Health plans are actively seeking to reduce spending on expensive biotech cancer drugs.
- Oncologists are resisting these cost-containment measures, citing the need to cover service costs.
- The practice of purchasing and marking up drug prices is defended by oncologists as vital for comprehensive cancer care.
Conclusions:
- A significant tension exists between cost containment in managed care and physician autonomy in cancer drug management.
- Oncologists view their current drug purchasing and pricing methods as integral to providing necessary patient services.
- Resolving this conflict requires addressing both the financial pressures on health plans and the clinical realities faced by oncologists.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.